Download FREE Report Sample
Download Free sampleFlupentixol has a strong antipsychotic effect, which is 4 ~ 8 times stronger than cloprothiazide, and the sedative effect is weaker.At the same time also anti - anxiety, anti - depression effect.Suitable for acute, chronic schizophrenia, depression and depressive neurosis.This product is easy to absorb, has first pass effect, through liver metabolism, kidney excretion.
Flupentixol Market contains market size and forecasts of Flupentixol in Global, including the following market information:
Global Flupentixol Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Flupentixol market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Flupentixol include H. Lundbeck, Sichuan Haisike Pharmaceutical, Chongqing Shenghuaxi Pharmaceutical, Chengdu Beite Pharmaceutical, Harbin Pharmaceutical Group, Hainan Yier Pharmaceutical, Shenzhen kangzhe Pharmaceutical and Sun Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Flupentixol companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Flupentixol Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Flupentixol Market Segment Percentages, by Type, 2021 (%)
Oral
Injection
Global Flupentixol Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Flupentixol Market Segment Percentages, by Application, 2021 (%)
Acute Phase
Consolidation Phase
Maintenance Phase
Global Flupentixol Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Flupentixol Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Flupentixol revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Flupentixol revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
H. Lundbeck
Sichuan Haisike Pharmaceutical
Chongqing Shenghuaxi Pharmaceutical
Chengdu Beite Pharmaceutical
Harbin Pharmaceutical Group
Hainan Yier Pharmaceutical
Shenzhen kangzhe Pharmaceutical
Sun Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
